Layton Patrick Mills
Founder chez CANNPAL ANIMAL THERAPEUTICS LIMITED
Profil
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd.
which was founded in 2016.
He held the titles of Chief Executive Officer, Director & MD at the time of founding.
Currently, he is a Non-Executive Director at MGC Pharmaceuticals Ltd.
where he started in 2023.
In 2021, he was the Chief Executive Officer at AusCann Group Holdings Ltd.
until 2022.
Postes actifs de Layton Patrick Mills
| Sociétés | Poste | Début |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 03/06/2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 01/06/2023 |
Anciens postes connus de Layton Patrick Mills
| Sociétés | Poste | Fin |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 13/09/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Entreprise privées | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
